The University of California San Diego School of Medicine’s Center for Medicinal Cannabis Research is seeking participants for a set of clinical trials exploring the effectiveness of cannabidiol (CBD) and tetrahydrocannabinol (THC) in treating symptoms of severe autism, anorexia nervosa, essential tremor, and early psychosis. The studies are small, each recruiting fewer than 80 participants. (Candid Chronicle)